Publications by authors named "Miriam Matas"

Claim this Profile
N
NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers.
Gonzalo Villapalos-García, Pablo Zubiaur, Dolores Ochoa, Paula Soria-Chacartegui, Marcos Navares-Gómez, Miriam Matas

Biomed Pharmacother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Variation in and Affects Amlodipine Pharmacokinetics and Safety.
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas

Pharmaceutics· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam.
Pablo Zubiaur, Laura Figueiredo-Tor, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Marcos Navares-Gómez, Miriam Matas

Biomed Pharmacother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline.
Pablo Zubiaur, Miriam Matas, Samuel Martín-Vílchez, Paula Soria-Chacartegui, Gonzalo Villapalos-García

Pharmaceutics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis